1
|
Kuwata T, Kashihara H, Kato C, Takeyama M, Yamaguchi A, Moriyama Y, Nakai C, Miwa K, Araki H, Narushima M, Yamasaki M, Hirama H, Okazoe H. Three-Year Outcomes of a Multicenter Study of Japanese-Style Laparoscopic Sacrocolpopexy. Int Urogynecol J 2024:10.1007/s00192-024-05954-6. [PMID: 39470780 DOI: 10.1007/s00192-024-05954-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2024] [Accepted: 09/13/2024] [Indexed: 11/01/2024]
Abstract
INTRODUCTION AND HYPOTHESIS Laparoscopic sacrocolpopexy(LSC) is widely performed and has been reported to safe and effective. However, statistical data on this technique are unavailable. Therefore, we designed the Japanese-style LSC, a further evolution of the French-style LSC, and initiated this multicenter study to prospectively evaluate its efficacy and safety. If the Japanese-style LSC is successful, we may be able to propose a more reliable and standardized procedure. METHODS This is a prospective study of Japanese-style LSC. The Japanese-style LSC is characterized by the dissection of the vaginal walls as distally as possible and fixation of the mesh with multiple sutures; fixation of the mesh on the promontory without traction; and closure of the peritoneum with high-level peritoneal sutures. We examined the primary (anatomical recurrence, adverse events, and quality of life) and secondary endpoints (voiding symptoms and sexual function) at 3 years postoperatively. RESULTS In anatomical recurrence, 24 patients (9.2%) were ≥ stage2 in the Pelvic Organ Prolapse Quantification system at 3 years postoperatively, of which 4 (1.5%) and 20 (7.7%) were stages III and II respectively. No mesh-related complications were observed, and each questionnaire showed predominant improvement, except for sexual and evacuation functions. CONCLUSIONS The Japanese-style LSC demonstrated superior anatomical and functional results and we propose it to be an effective procedure.
Collapse
Affiliation(s)
- Tomoko Kuwata
- The Department of Female Urology/Urogynecology Center, Daiichi Towakai Hospital, 2-17, Miyano-cho, Takatsuki City, Osaka, 569-0081, Japan.
| | - Hiromi Kashihara
- The Department of Female Urology/Urogynecology Center, Daiichi Towakai Hospital, 2-17, Miyano-cho, Takatsuki City, Osaka, 569-0081, Japan
| | - Chikako Kato
- The Department of Female Urology/Urogynecology Center, Daiichi Towakai Hospital, 2-17, Miyano-cho, Takatsuki City, Osaka, 569-0081, Japan
| | - Masami Takeyama
- The Department of Female Urology/Urogynecology Center, Daiichi Towakai Hospital, 2-17, Miyano-cho, Takatsuki City, Osaka, 569-0081, Japan
| | - Akane Yamaguchi
- The Department of Urogynecology Center, Gifu Red Cross Hospital, 3-36 Iwakura-cho, Gifu City, Gifu, 502-8511, Japan
| | - Youji Moriyama
- The Department of Urogynecology Center, Gifu Red Cross Hospital, 3-36 Iwakura-cho, Gifu City, Gifu, 502-8511, Japan
| | - Chie Nakai
- The Department of Urogynecology Center, Gifu Red Cross Hospital, 3-36 Iwakura-cho, Gifu City, Gifu, 502-8511, Japan
| | - Kosei Miwa
- The Department of Urogynecology Center, Gifu Red Cross Hospital, 3-36 Iwakura-cho, Gifu City, Gifu, 502-8511, Japan
| | - Hidemori Araki
- The Department of Female urology/Urogynecology center, Meitetsu Hospital, 2-26-11 Sako, Nishi-ku, Nagoya City, Aichi, 451-8511, Japan
| | - Masahiro Narushima
- The Department of Female urology/Urogynecology center, Meitetsu Hospital, 2-26-11 Sako, Nishi-ku, Nagoya City, Aichi, 451-8511, Japan
| | - Mari Yamasaki
- The Department of Urology, KKR Takamatsu Hospital, 4-18 Tenjinmae, Takamatsu City, Kagawa, 760-0018, Japan
| | - Hiromi Hirama
- The Department of Urology, KKR Takamatsu Hospital, 4-18 Tenjinmae, Takamatsu City, Kagawa, 760-0018, Japan
| | - Homare Okazoe
- The Department of Urology, KKR Takamatsu Hospital, 4-18 Tenjinmae, Takamatsu City, Kagawa, 760-0018, Japan
| |
Collapse
|
2
|
Alsahabi JA, Alsary S, Abolfotouh MA. The Outcome of Sacrocolpopexy/Sacrohysteropexy for Patients with Pelvic Organ Prolapse and Predictors of Anatomical Failure. Int J Womens Health 2023; 15:1093-1105. [PMID: 37483888 PMCID: PMC10362893 DOI: 10.2147/ijwh.s413729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2023] [Accepted: 07/11/2023] [Indexed: 07/25/2023] Open
Abstract
Background Pelvic organ prolapse (POP) is a medical condition that profoundly impacts women's quality of life. Unfortunately, the literature lacks long-term predictors and risk factors for its recurrence. This study aims to assess the efficacy and safety of Sacrocolpopexy/Sacrohysteropexy and to identify the predictors of recurrence in a Saudi setting. Methods In a retrospective cohort study, all patients who underwent Sacrocolpopexy (n=144) and Sacrohysteropexy (n=56) between 2009-2021 were followed up. Electronic medical records were examined to collect data on the following: Patient characteristics [age, parity, BMI, and past medical and surgical history], prolapse-related characteristics/symptoms, Surgery-related characteristics [type and approach of surgery, mesh type, and concomitant surgery], and Outcome characteristics. Postoperative anatomical success and failure rates were determined according to the Baden-Walker classification. Logistic regression analysis was applied to identify the predictors of overall anatomical failure of Sacrocolpopexy. Significance was considered at p<0.05. Results Success rates of 96.8%, 99.4%, and 85.2% were detected in the anterior, apical, and posterior vaginal prolapse, respectively, with an overall success rate of 83.1%. The overall failure rate was 15.9%, with an incidence density of 5.98 per 100 women-years. The onset of failure in 27 failure cases ranged from 40 days to 11.5 years postoperative. After adjustment for the possible potential confounders, older age (OR=1.06, 95% CI:1.01‒1.13, p=0.03) and the presence of diabetes (OR=4.93, 95% CI:1.33‒18.33, p=0.02) were the only significant predictors of operation failure. As for complications, six cases (3.6%) required reoperation, two cases (1.2%) had a bowel obstruction two and seven years after surgery, and one patient (0.6%) had vaginal mesh exposure. Conclusion The outcomes of Sacrocolpopexy/Sacrohysteropexy in our study are comparable to those in previous studies. Diabetes and elder age at the time of the surgery played a role in predicting recurrence. Sacrocolpopexy has a long-term profile of safety and efficacy. These findings could be key to stratifying surgical plans for pelvic organ prolapse cases.
Collapse
Affiliation(s)
- Jawaher A Alsahabi
- Department Urogynecology & Reconstructive Female Pelvic Surgery, King Abdul-Aziz Medical City, King Saud Ben Abdu Aziz University for Health Sciences (KSAU-HS), Ministry of National Guard-Health Affairs, Riyadh, 22490, Saudi Arabia
- King Abdullah International Medical Research Center (KAIMRC), King Saud Ben Abdul Aziz University for Health Sciences (KSAU-HS), Ministry of National Guard-Health Affairs, Riyadh, 11481, Saudi Arabia
| | - Saeed Alsary
- Department Urogynecology & Reconstructive Female Pelvic Surgery, King Abdul-Aziz Medical City, King Saud Ben Abdu Aziz University for Health Sciences (KSAU-HS), Ministry of National Guard-Health Affairs, Riyadh, 22490, Saudi Arabia
- King Abdullah International Medical Research Center (KAIMRC), King Saud Ben Abdul Aziz University for Health Sciences (KSAU-HS), Ministry of National Guard-Health Affairs, Riyadh, 11481, Saudi Arabia
| | - Mostafa A Abolfotouh
- King Abdullah International Medical Research Center (KAIMRC), King Saud Ben Abdul Aziz University for Health Sciences (KSAU-HS), Ministry of National Guard-Health Affairs, Riyadh, 11481, Saudi Arabia
| |
Collapse
|
3
|
Sassani JC, Clark SG, McGough CE, Shepherd JP, Bonidie M. Sacrocolpopexy experience with a novel robotic surgical platform. Int Urogynecol J 2022; 33:3255-3260. [PMID: 35312804 DOI: 10.1007/s00192-022-05155-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Accepted: 02/20/2022] [Indexed: 12/01/2022]
Abstract
INTRODUCTION AND HYPOTHESIS The objective was to describe early experience performing sacrocolpopexy using a novel robotic surgical platform. METHODS This is a case series of all women who underwent robotic-assisted sacrocolpopexy using a new robotics platform (TransEnterix Senhance) between January 2019 and July 2021. All sacrocolpopexies were performed by a single Female Pelvic Medicine and Reconstructive surgeon at a large academic institution. Perioperative information including complications was abstracted from the medical record. Anatomical recurrence was defined as any anatomical point at or past the hymen (≥0). Data are descriptive, with Mann-Whitney U test used for comparison of operative time between the first and second half of the patients. RESULTS A total of 25 sacrocolpopexies were performed using the new robotics platform. Mean age was 62.3 years (±9.2) and mean BMI was 26.5 (±3.8). Ten (40.0%) patients had a prior hysterectomy. Most (n = 21, 84.0%) had stage III or IV prolapse preoperatively. Mean operative time was 210.2 min (±48.6) and median estimated blood loss was 35 ml (IQR 25-50). Mean operative time decreased between the first and second half of the patients (231.7 min vs 190.3 min, p = 0.047). There were no major intraoperative complications. Median follow-up time was 16 weeks (IQR 4-34) and there were no subjective recurrences or retreatments during this period. Two patients (8.0%) had anatomical recurrence without subjective bother. There were two postoperative readmissions (8.0%) within 30 days for small bowel obstruction, one treated surgically and the other with nonsurgical management. CONCLUSIONS Our case series demonstrates feasibility and successful early adoption of a new robotics platform for robotic sacrocolpopexy.
Collapse
Affiliation(s)
- Jessica C Sassani
- Division of Urogynecology, Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
| | - Stephanie Glass Clark
- Division of Urogynecology, Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| | - Christine E McGough
- Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| | - Jonathan P Shepherd
- Department of Obstetrics & Gynecology, University of Connecticut Health Center, Farmington, CT, USA
| | - Michael Bonidie
- Division of Urogynecology, Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| |
Collapse
|